• LAST PRICE
    5.2500
  • TODAY'S CHANGE (%)
    Trending Up0.6700 (14.6288%)
  • Bid / Lots
    5.1900/ 10
  • Ask / Lots
    5.2300/ 5
  • Open / Previous Close
    5.2300 / 4.5800
  • Day Range
    Low 5.1300
    High 5.4300
  • 52 Week Range
    Low 1.7500
    High 7.7599
  • Volume
    147,893
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 4.58
TimeVolumeNBTX
09:32 ET27235.23
09:34 ET24865.1901
09:36 ET24105.205
09:38 ET2505.21
09:39 ET1205.21
09:45 ET24165.19
09:48 ET1005.21
09:50 ET40005.2599
09:52 ET170315.35
09:54 ET29895.315
09:56 ET9685.3
09:59 ET13905.26
10:01 ET113675.25
10:03 ET35755.22
10:06 ET9005.2593
10:14 ET4155.26
10:19 ET4495.16
10:21 ET15755.15
10:24 ET9005.25
10:32 ET3005.2495
10:48 ET2005.1903
10:51 ET22645.25
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNBTX
Nanobiotix SA
165.0M
-3.0x
---
United StatesMACK
Merrimack Pharmaceuticals Inc
178.5M
-102.7x
---
United StatesOPT
Opthea Ltd
179.6M
-1.2x
---
United StatesOCEA
Ocean Biomedical Inc
180.3M
-71.8x
---
United StatesCTXR
Citius Pharmaceuticals Inc
184.3M
-5.8x
---
United StatesCUE
Cue Biopharma Inc
172.7M
-3.0x
---
As of 2023-06-01

Company Information

Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.

Contact Information

Headquarters
60 rue de WattigniesPARIS, France 75012
Phone
---
Fax
---

Executives

Independent Chairman of the Supervisory Board
Gary Phillips
Chairman of the Management Board, Chief Executive Officer, Co-Founder
Laurent Levy
Independent Vice Chairwoman of the Supervisory Board
Anne-Marie Graffin
Chief Financial Officer, Member of the Management Board
Bart Van Rhijn
Chief People Officer, Member of the Management Board
Anne-Juliette Hermant

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$165.0M
Revenue (TTM)
$0.00
Shares Outstanding
34.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.75
Book Value
$-0.83
P/E Ratio
-3.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.